CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
centrifuged fat graft +1 moregenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01771913
NCT01771913Phase 2Completed

Immunophenotyping of Fresh Stromal Vascular Fraction From Adipose Derived Stem Cells (ADSC) Enriched Fat Grafts for Refinements of Reconstructed Breasts

University of Sao Paulo·interventional·Posted Jan 18, 2013·Updated Aug 24, 2015

In Brief

A Phase 2 clinical trial evaluating centrifuged fat graft and ADSCs enriched fat graft for Breast Reconstruction and 2 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate if there is a relationship between the take of fat grafts with and without ADSCs and the presence of specific surface markers on the cells of the stromal vascular fraction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil
Collaborators--

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 18, 2013
Enrollment StartMar 1, 2012
Primary CompletionSep 1, 2014
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 13.5 years ago

Interventions

centrifuged fat graftgenetic

fat from the abdominal subcutaneous tissue will be taken by vacuum assisted lipectomy and immediately prepared to be grafted in the reconstructed breast that presents contour irregularities and/or volume insufficiency. No adipose derived stem cells will enrich the fat grafts in this group.

ADSCs enriched fat graftgenetic

fat from the abdominal subcutaneous tissue will be taken by suction assisted lipectomy and stromal vascular fraction will be isolated and immediately added to the fat graft that will be employed to improve contour irregularities and volume insufficiency of reconstructed breasts.